TY - JOUR
T1 - Biocompatibility and osteoinductive activity of nano-hydroxyapatite/chitosan/ poly(lactide-co-glycolide) scaffolds in vitro
AU - Wang, Fei
AU - Zhou, Hong
AU - Guo, Yu cheng
AU - Su, Xiao xia
AU - Rao, Guo zhou
AU - Zhao, Xiao peng
PY - 2014
Y1 - 2014
N2 - Background: Studies have found that combination of two of chitosan (CS), nano-hydroxyapatite (nHA) and poly(lactide-co-glycolide) (PLGA) can improve the mechanical properties and biocompatibility of the composite stent in certain extent as well as improve osteogenic differentiation of the cells, but there is a certain distance from the ideal bone tissue engineering scaffolds. Objective: To study biocompatibility and osteoinductive activity of nHA/CS/PLGA scaffolds with different proportions in vitro. Methods: nHA/CS/PLGA scaffolds were prepared at mass ratio of 10:10:80, 10:20:70, 20:10:70 respectively by particle leaching method. And human bone marrow stem cells (hBMSCs) were co-cultured with these scaffolds in vitro. Adhesion, proliferation, and osteoinductive activity of these scaffolds were examined qualitatively and quantitatively by growth curve of hBMSCs on scaffolds. Gene expression of alkaline phosphatase activity and osteocalcin was detected by RT-PCR. Results and Conclusion: hBMSCs could be attached, proliferated, and osteoinduced better on the nHA/CS/PLGA scaffold with the mass ratio of 20:10:70, compared to the other two groups of scaffolds. The differences were significant statistically (P < 0.05). Alkaline phosphatase and osteocalcin expressions were respectively higher in the scaffold with the mass ratio of 20:10:70 after 9-27 days of co-culture and 15-27 days of co-culture, in comparison with the other two groups of scaffolds. These findings indicate that the nHA/CS/PLGA scaffolds with the mass ratio of 20:10:70 demonstrated preferable biocompatibility and osteogenic inductivity, which is expected to be a promising scaffold material for bone tissue engineering.
AB - Background: Studies have found that combination of two of chitosan (CS), nano-hydroxyapatite (nHA) and poly(lactide-co-glycolide) (PLGA) can improve the mechanical properties and biocompatibility of the composite stent in certain extent as well as improve osteogenic differentiation of the cells, but there is a certain distance from the ideal bone tissue engineering scaffolds. Objective: To study biocompatibility and osteoinductive activity of nHA/CS/PLGA scaffolds with different proportions in vitro. Methods: nHA/CS/PLGA scaffolds were prepared at mass ratio of 10:10:80, 10:20:70, 20:10:70 respectively by particle leaching method. And human bone marrow stem cells (hBMSCs) were co-cultured with these scaffolds in vitro. Adhesion, proliferation, and osteoinductive activity of these scaffolds were examined qualitatively and quantitatively by growth curve of hBMSCs on scaffolds. Gene expression of alkaline phosphatase activity and osteocalcin was detected by RT-PCR. Results and Conclusion: hBMSCs could be attached, proliferated, and osteoinduced better on the nHA/CS/PLGA scaffold with the mass ratio of 20:10:70, compared to the other two groups of scaffolds. The differences were significant statistically (P < 0.05). Alkaline phosphatase and osteocalcin expressions were respectively higher in the scaffold with the mass ratio of 20:10:70 after 9-27 days of co-culture and 15-27 days of co-culture, in comparison with the other two groups of scaffolds. These findings indicate that the nHA/CS/PLGA scaffolds with the mass ratio of 20:10:70 demonstrated preferable biocompatibility and osteogenic inductivity, which is expected to be a promising scaffold material for bone tissue engineering.
KW - Biocompatible materials
KW - Chitosan
KW - Hydroxyapatites
KW - Nanoparticles
UR - https://www.scopus.com/pages/publications/84940321321
U2 - 10.3969/j.issn.2095-4344.2014.08.009
DO - 10.3969/j.issn.2095-4344.2014.08.009
M3 - 文章
AN - SCOPUS:84940321321
SN - 1673-8225
VL - 18
SP - 1198
EP - 1204
JO - Chinese Journal of Tissue Engineering Research
JF - Chinese Journal of Tissue Engineering Research
IS - 8
ER -